Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer
Clinical trial NCT03484221 · UNKNOWN
Trial details
- NCT number
- NCT03484221
- Sponsor
- China Medical University, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-01
- Primary completion
- 2021-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.